BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29352379)

  • 1. Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT.
    Jeon SK; Lee JM; Joo I; Lee DH; Ahn SJ; Woo H; Lee MS; Jang JY; Han JK
    Eur Radiol; 2018 Aug; 28(8):3484-3493. PubMed ID: 29352379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study.
    Marion-Audibert AM; Vullierme MP; Ronot M; Mabrut JY; Sauvanet A; Zins M; Cuilleron M; Sa-Cunha A; Lévy P; Rode A
    AJR Am J Roentgenol; 2018 Nov; 211(5):W217-W225. PubMed ID: 30240298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI.
    Riviere DM; van Geenen EJM; van der Kolk BM; Nagtegaal ID; Radema SA; van Laarhoven CJHM; Hermans JJ
    Abdom Radiol (NY); 2019 May; 44(5):1756-1765. PubMed ID: 30659309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
    Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
    BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer.
    Kim HW; Lee JC; Paik KH; Kang J; Kim YH; Yoon YS; Han HS; Kim J; Hwang JH
    Surgery; 2017 Jun; 161(6):1579-1587. PubMed ID: 28237643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
    Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
    Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.
    Ghaneh P; Hanson R; Titman A; Lancaster G; Plumpton C; Lloyd-Williams H; Yeo ST; Edwards RT; Johnson C; Abu Hilal M; Higginson AP; Armstrong T; Smith A; Scarsbrook A; McKay C; Carter R; Sutcliffe RP; Bramhall S; Kocher HM; Cunningham D; Pereira SP; Davidson B; Chang D; Khan S; Zealley I; Sarker D; Al Sarireh B; Charnley R; Lobo D; Nicolson M; Halloran C; Raraty M; Sutton R; Vinjamuri S; Evans J; Campbell F; Deeks J; Sanghera B; Wong WL; Neoptolemos JP
    Health Technol Assess; 2018 Feb; 22(7):1-114. PubMed ID: 29402376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer.
    Holzapfel K; Reiser-Erkan C; Fingerle AA; Erkan M; Eiber MJ; Rummeny EJ; Friess H; Kleeff J; Gaa J
    Abdom Imaging; 2011 Apr; 36(2):179-84. PubMed ID: 20563868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer.
    Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Aramaki T; Endo M; Uesaka K
    Pancreatology; 2017; 17(3):451-456. PubMed ID: 28298257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.
    Lee KH; Lee JM; Park JH; Kim JH; Park HS; Yu MH; Yoon JH; Han JK; Choi BI
    Korean J Radiol; 2013; 14(6):894-904. PubMed ID: 24265564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography.
    Chew C; O'Dwyer PJ
    Singapore Med J; 2016 Jun; 57(6):334-8. PubMed ID: 27353741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false negatives.
    LeBlanc M; Kang J; Costa AF
    Eur Radiol; 2023 Nov; 33(11):7656-7664. PubMed ID: 37266655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective comparison of 3T MRI with diffusion-weighted imaging and MDCT for the preoperative TNM staging of gastric cancer.
    Joo I; Lee JM; Kim JH; Shin CI; Han JK; Choi BI
    J Magn Reson Imaging; 2015 Mar; 41(3):814-21. PubMed ID: 24677322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.
    Scharitzer M; Ba-Ssalamah A; Ringl H; Kölblinger C; Grünberger T; Weber M; Schima W
    Eur Radiol; 2013 Aug; 23(8):2187-96. PubMed ID: 23519439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of surgical resectability of pancreatic adenocarcinomas with multidetector computed tomography: what are the possibilities and problems?
    Işcanlı E; Türkvatan A; Bostancı EB; Sakaoğulları Z
    Turk J Gastroenterol; 2014 Aug; 25(4):416-23. PubMed ID: 25254525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time ultrasonography-computed tomography fusion imaging for staging of hepatic metastatic involvement in patients with colorectal cancer: initial results from comparison to US seeing separate CT images and to multidetector-row CT alone.
    Stang A; Keles H; Hentschke S; Seydewitz C; Keuchel M; Pohland C; Dahlke J; Weilert H; Wessling J; Malzfeldt E
    Invest Radiol; 2010 Aug; 45(8):491-501. PubMed ID: 20458251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of liver magnetic resonance imaging after standard staging abdominopelvic computed tomography to evaluate newly diagnosed colorectal cancer patients.
    Han K; Park SH; Kim KW; Kim HJ; Lee SS; Kim JC; Yu CS; Lim SB; Joo YS; Kim AY; Ha HK
    Ann Surg; 2015 Mar; 261(3):480-6. PubMed ID: 24866542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT.
    Park HS; Lee JM; Choi HK; Hong SH; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Sep; 30(3):586-95. PubMed ID: 19711405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.